MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · IEX Real-Time Price · USD
0.875
-0.005 (-0.57%)
Jul 22, 2024, 11:34 AM EDT - Market open
MiNK Therapeutics Employees
MiNK Therapeutics had 31 employees as of December 31, 2023. The number of employees decreased by 6 or -16.22% compared to the previous year.
Employees
31
Change (1Y)
-6
Growth (1Y)
-16.22%
Revenue / Employee
n/a
Profits / Employee
-$664,036
Market Cap
31.85M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 31 | -6 | -16.22% |
| Dec 31, 2022 | 37 | 4 | 12.12% |
| Dec 31, 2021 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CareCloud | 3,600 |
| Evogene | 142 |
| Pluri | 134 |
| Spectral AI | 78 |
| Equillium | 44 |
| Lipocine | 17 |
| SeaStar Medical Holding | 12 |
| Akari Therapeutics, | 12 |
INKT News
- 6 weeks ago - MiNK Therapeutics Announces Virtual Annual Shareholders Meeting - GlobeNewsWire
- 2 months ago - MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting - GlobeNewsWire
- 2 months ago - MiNK Reports First Quarter 2024 Results - GlobeNewsWire
- 2 months ago - MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer - GlobeNewsWire
- 2 months ago - MiNK to Provide Corporate Update and First Quarter 2024 Financial Report - GlobeNewsWire
- 3 months ago - MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR - GlobeNewsWire
- 4 months ago - MiNK Reports Fourth Quarter and Year-End 2023 Results - GlobeNewsWire
- 4 months ago - MiNK to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report - GlobeNewsWire